List of insiders holdings for AN2 Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Leonard Braden Michael 10% Owner | 2025-06-16 15:40:59 | 0 3,017,432 | 3,017,432 | Form 4 |
| 2 | Aziz Kabeer Director | 2026-07-10 19:41:32 | 59,106 2,373,500 | 2,432,606 | Form 4 |
| 3 | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 2025-02-28 19:57:57 | 2,373,500 0 | 2,373,500 | Form 13G |
| 4 | Easom Eric Chief Executive Officer | 2026-03-23 19:00:23 | 742,649 0 | 742,649 | Form 4 |
| 5 | Readnour Robin Shane Director | 2026-08-19 17:58:27 | 9,077 633,867 | 642,944 | Form 4 |
| 6 | Day Lucy Chief Financial Officer | 2026-03-23 19:16:42 | 221,965 0 | 221,965 | Form 4 |
| 7 | Eizen Joshua M See Remarks | 2026-07-10 18:15:57 | 206,554 0 | 206,554 | Form 4 |
| 8 | Chanda Sanjay Chief Development Officer | 2026-03-23 19:16:39 | 165,615 0 | 165,615 | Form 4 |
| 9 | Zakrzewski Joseph S Director | 2026-08-14 14:12:12 | 145,538 0 | 145,538 | Form 4 |
| 10 | Marks Gilbert Lynn Director | 2026-07-10 19:41:06 | 81,873 0 | 81,873 | Form 4 |
| 11 | Williams Sarah Joanne Principal Accounting Officer | 2026-06-02 16:31:36 | 66,583 0 | 66,583 | Form 4 |
| 12 | Wong Stephanie Director | 2026-03-23 19:08:16 | 59,103 0 | 59,103 | Form 4 |
| 13 | Prior Stephen David Chief Strategy Officer | 2026-01-07 20:15:13 | 59,086 0 | 59,086 | Form 4 |
| 14 | Eckburg Paul Chief Medical Officer | 2024-03-29 16:19:03 | 51,416 0 | 51,416 | Form 4/A |
| 15 | Spigelman Melvin K Director | 2026-03-23 19:04:19 | 51,045 0 | 51,045 | Form 4 |
| 16 | FitzPatrick Margaret M Director | 2026-03-23 19:09:55 | 45,567 0 | 45,567 | Form 4 |
| 17 | Krause Kevin Michael Chief Strategy Officer | 2024-03-29 16:17:22 | 31,914 0 | 31,914 | Form 4/A |
| 18 | Martin Patricia A. Director | 2026-07-10 19:40:14 | 18,863 0 | 18,863 | Form 4 |
| 19 | Nazak Michael Adrian Chief Accounting Officer | 2023-02-17 19:23:22 | 16,600 0 | 16,600 | Form 4 |
| 20 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 2025-02-14 18:27:01 | 0 0 | 0 | Form 13G |
| 21 | Trenor Cameron C. III Chief Medical Officer | 2026-08-27 14:15:57 | 0 0 | 0 | Form 3 |